Acute Promyelocytic Leukemia Cells (APLC)

[Edit]

Acute Promyelocytic Leukemia Cells (APLC)

Acute promyelocytic leukemia (APML, APL) is the M3 subtype of acute myelogenous leukemia (AML), a cancer of the white blood cells. In APL, there is an abnormal accumulation of immature granulocytes called promyelocytes. The disease is characterized by a chromosomal translocation involving the retinoic acid receptor alpha (RARα or RARA) gene and is distinguished from other forms of AML by its responsiveness to all-trans retinoic acid (ATRA; also known as tretinoin) therapy.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Cells n/a Acute Promyelocytic Leukemia Cells (APLC) Primary Cells Customized Service Offer
Extracts n/a Extract of Acute Promyelocytic Leukemia Cells (APLC) Total Protein/DNA/RNA Extract Customized Service Offer
Mediums n/a Medium for Acute Promyelocytic Leukemia Cells (APLC) (If Necessary) Cell Culture Medium Customized Service Offer

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Cells n/a Acute Promyelocytic Leukemia Cells (APLC) Primary Cells Customized Service Offer
Extracts n/a Extract of Acute Promyelocytic Leukemia Cells (APLC) Total Protein/DNA/RNA Extract Customized Service Offer
Mediums n/a Medium for Acute Promyelocytic Leukemia Cells (APLC) (If Necessary) Cell Culture Medium Customized Service Offer